Evidence map›Paper›PMID 35810265›Full record

Observational studyDrug safety2022

Hip Fracture Risk After Treatment with Tramadol or Codeine: An Observational Study.

Erica A Voss, Saberi Rana Ali, Arun Singh, Peter R Rijnbeek, Martijn J Schuemie, Daniel Fife

Open access · hybridAbstract readObservational Study
In one paragraph

Observational study in Drug safety, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Innovations in pharmacovigilance studies of medicines in older people.British journal of clinical pharmacology · 2025
    Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Erica A VossJanssen Research & Development LLC, 920 Route 202, Raritan, NJ, 08869, USA. evoss3@its.jnj.com.ORCID http://orcid.org/0000-0002-0651-0613
Saberi Rana AliJanssen Research & Development LLC, 920 Route 202, Raritan, NJ, 08869, USA.
Arun SinghJanssen Research & Development LLC, 920 Route 202, Raritan, NJ, 08869, USA.ORCID http://orcid.org/0000-0002-9567-6139
Peter R RijnbeekObservational Health Data Sciences and Informatics (OHDSI), OHDSI Collaborators, New York, NY, USA.
Martijn J SchuemieJanssen Research & Development LLC, 920 Route 202, Raritan, NJ, 08869, USA.ORCID http://orcid.org/0000-0002-0817-5361
Daniel FifeJanssen Research & Development LLC, 920 Route 202, Raritan, NJ, 08869, USA.
Janssen (United States) · USErasmus MC · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionHip fractures among older people are a major public health issue, which can impact quality of life and increase mortality within the year after they occur. A recent observational study found an increased risk of hip fracture in subjects who were new users of tramadol compared with codeine. These drugs have somewhat different indications. Tramadol is indicated for moderate to severe pain and can be used for an extended period; codeine is indicated for mild to moderate pain and cough suppression.

objectiveIn this observational study, we compared the risk of hip fracture in new users of tramadol or codeine, using multiple databases and analytical methods.

methodsUsing data from the Clinical Practice Research Datalink and three US claims databases, we compared the risk of hip fracture after exposure to tramadol or codeine in subjects aged 50-89 years. To ensure comparability, large-scale propensity scores were used to adjust for confounding.

resultsWe observed a calibrated hazard ratio of 1.10 (95% calibrated confidence interval 0.99-1.21) in the Clinical Practice Research Datalink database, and a pooled estimate across the US databases yielded a calibrated hazard ratio of 1.06 (95% calibrated confidence interval 0.97-1.16).

conclusionsOur results did not demonstrate a statistically significant difference between subjects treated for pain with tramadol compared with codeine for the outcome of hip fracture risk.

Indexed as

Hip FracturesTramadolAgedAnalgesics, OpioidCodeineHumansPainQuality of LifeAnalgesics, OpioidCodeineTramadol

Identifiers

PMID35810265
PMCPMC9296392
OpenAlexW4284957861

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.